Andy Lundin, Author at Gastroenterology Advancements

Safety Profile of Biosimilars in Gastroenterology: Monitoring and Managing Risks

Posted by Andy Lundin | Jul 30, 2024 | Biologic Therapies |

Biosimilars are designed to be highly similar to their reference products, offering comparable safety and efficacy but at a reduced cost.

Posted by Andy Lundin | Jul 30, 2024 | Pharmacotherapy |

JAK inhibitors have emerged as a promising targeted therapy for inflammatory bowel disease, including Crohn’s disease and ulcerative colitis.

Laparoscopic surgery, a minimally invasive technique, has become a popular alternative to traditional open surgery for GI procedures.

Posted by Andy Lundin | Jul 30, 2024 | X-ray |

Digital radiography (DR) has become an integral tool in gastrointestinal (GI) diagnosis, offering...

Posted by Andy Lundin | Jul 30, 2024 | CT Scanning |

Dual-energy computed tomography (DECT) is revolutionizing gastrointestinal (GI) imaging by...